Concepedia
Statistics
Publications
35
Citations
1.3K
H-Index
23
Active since
1997
Affiliations
AstraZeneca (Sweden)(Current)
Medivir (Sweden)
King's College London
Karolinska University Hospital
Lund University
Erik Lindström is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and pharmacodynamics.
Publications per year
1997–2023
CB<sub>1</sub>Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents
Mikael Brusberg, Susanne Arvidsson, Daiwu Kang et al. · Journal of Neuroscience · 2009 · 84 citations · Full text
Medicine, Pharmacology, Neuropharmacology +16
The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis
Erik Lindström, Biljana Rizoska, Karin Tunblad et al. · Journal of Translational Medicine · 2018 · 81 citations · Full text
Medicine, Orthopaedic Surgery, Orthopedic Surgery +16
Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study
Ulrich Baumann, Ekkehard Sturm, Florence Lacaille et al. · Clinics and Research in Hepatology and Gastroenterology · 2021 · 73 citations
Medicine, Child Health, Pediatrics +12
Neurokinin 1 Receptor Antagonists: Correlation between in Vitro Receptor Interaction and in Vivo Efficacy
Erik Lindström, Ingrid Påhlman, Ingela Ahlstedt et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 70 citations
Medicine, Medicinal Chemistry, Pharmacology +15
Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S
Silke Haerteis, Matteus Krappitz, Marko Bertog et al. · Pflügers Archiv - European Journal of Physiology · 2012 · 68 citations · Full text
Life Sciences, Biochemistry, Physiology +17
1–5 of 35